Key result
PFNA-II linked to good functional outcomes but high mortality in unstable intertrochanteric femur fractures.
Why the study?
PFNA-II is designated to treat unstable osteoporotic intertrochanteric fractures in Asian populations, but its clinico-radiological and functional outcomes needed evaluation.
Does PFNA-II improve functional and clinico-radiological outcomes in patients with unstable intertrochanteric femur fractures?
Observational (n=25)
No
Does PFNA-II improve functional and clinico-radiological outcomes in patients with unstable intertrochanteric femur fractures?
PFNA-II is a feasible implant providing good functional outcomes for unstable intertrochanteric femur fractures in the elderly Indian population.
May support PFNA-II in small elderly cohorts; hypothesis-generating and should not yet change practice without RCTs.
Background: In the Asian population, proximal femoral nail anti-rotation II (PFNA-II), an implant device is one of the treatment modalities designated to treat unstable osteoportotic intertrochanteric fractures. The aim of the present study was to evaluate the functional outcome of PFNA-II in intertrochanteric femur fractures (that includes both stable and unstable). Objective: The objective is to analyze clinico-radiological and functional outcomes of unstable intertrochanteric fractures by PFNA-II. Methodology: This was a prospective study conducted in the Department of Orthopaedics at Indira Gandhi Government Medical College, Nagpur (Vidarbha region) from August 2018 to August 2020. Patients’ demographic data such as age, gender, occupation, mode of injury, mode of trauma, presence of any co-morbidities, and fracture classification of the normal hip were recorded, from all the included patients 24 months follow-up was noted. The Boyd and Griffin’s classification was used. In the present study, the implant-related complications, including blade cutout, varus collapse, and loss of reduction, were observed. The functional evaluation of the patients was done based on the Modified Harris Hip Score. Outcome of the Study: Approximately 25 patients with radiological diagnosis of unstable intertrochanteric femur fractures were considered, out of which 13 (52%) patients were male and 12 (48%) patients were female, with the mean age of 68.61 ± 7.79 years, over the range of 40–90 years. The majority of cases were found to be in Boyd and Griffin classification, i.e., around 15 (60%), while in the Type III classification, there were 10 (40%) cases, and in the Type IV classification none of the cases were noted. Conclusion: PFNA-II provides good outcomes, low morbidity, and high mortality in elderly Indian populations with unstable intertrochanteric fractures. To the best of our knowledge, this was the first study done in Vidarbha region that focuses on the utility and feasibility of PFNA-II implant and represents its functional outcome.
No takes yet. Share an insight, caveat, or question.
Kamal et al. (2024) conducted an observational in Unstable intertrochanteric femur fractures (n=25). Proximal femoral nail anti-rotation II (PFNA-II) was evaluated on Functional outcome based on the Modified Harris Hip Score and clinico-radiological outcomes. Treatment with PFNA-II provided good functional outcomes, low morbidity, and high mortality in 25 patients with unstable intertrochanteric femur fractures over 24 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: